Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Sensei Biotherapeutics, Inc.

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21
   10-Q10-Q10-Q10-Q10-Q10-K10-Q10-Q
Net income    -45.7-42.0-41.2-36.8-32.6-28.2
Depreciation and amortization    0.80.80.70.70.40.4
Stock-based compensation       -4.8  
Change in working capital   [+]  1.6-0.34.50.72.3-2.3
Other operating activities    10.810.310.69.95.95.3
Cash from operations    -37.3-36.1-30.2-30.3-25.1-25.3
   
Capital expenditures    3.84.04.55.03.62.4
Purchases of short-term investments, net    518.6508.0566.9551.0188.8147.1
Other cash from investing    -482.9-481.5-701.9-699.2-341.4-298.9
Cash from investing    39.530.5-130.4-143.1-149.0-149.4
   
Other cash from financing    -0.30.10.0163.9179.9188.4
Cash from financing    -0.30.10.0163.9179.9188.4
   
Free cash flow    -33.5-32.1-25.7-25.3-21.5-22.9
        Per share (diluted)    ($1.12)($1.07)($0.86)($0.94)($1.05)($1.73)

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy